Evidence map›Paper›PMID 38273863›Full record

ReviewSynthetic and systems biotechnology2024

Engineering Rubisco to enhance CO

Lei Zhao, Zhen Cai, Yin Li, Yanping Zhang

Open access · goldAbstract readReview
In one paragraph

Review in Synthetic and systems biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Solar Air-to-Fuel Technologies for a Circular Carbon Economy.Journal of the American Chemical Society · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. RuBisCO-based COFrontiers in bioengineering and biotechnology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Using supervised machine-learning approaches to understand abiotic stress tolerance and design resilient crops.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lei ZhaoCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Zhen CaiCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Yin LiCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Yanping ZhangCAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
State Key Laboratory of Microbial ResourcesMicrobiology Institute of Shaanxi · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) is a pivotal enzyme that mediates the fixation of CO

Indexed as

Carbon fixation pathwayEnzyme engineeringMicrobialPlant CO2 fixationRubiscoSynthetic biology

Identifiers

PMID38273863
PMCPMC10809010
OpenAlexW4390245833

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.